Murphy Middleton Hinkle & Parker’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.33M Hold
3,661
0.54% 56
2026
Q1
$1.29M Buy
+3,661
New +$1.31M 0.6% 49
2025
Q4
Sell
-3,629
Closed -$1.02M 137
2025
Q3
$1.02M Sell
3,629
-4
-0.1% -$1.16K 0.5% 58
2025
Q2
$1.13M Hold
3,633
0.63% 46
2025
Q1
$1.13M Hold
3,633
0.63% 46
2024
Q4
$947K Sell
3,633
-3
-0.1% -$890 0.54% 58
2024
Q3
$1.17M Sell
3,636
-3
-0.1% -$981 0.63% 49
2024
Q2
$1.14M Sell
3,639
-110
-3% -$32.3K 0.66% 46
2024
Q1
$1.07M Hold
3,749
0.62% 54
2023
Q4
$1.08M Sell
3,749
-3
-0.1% -$817 0.67% 49
2023
Q3
$1.01M Sell
3,752
-190
-5% -$47.4K 0.65% 48
2023
Q2
$875K Hold
3,942
0.55% 57
2023
Q1
$953K Hold
3,942
0.59% 52
2022
Q4
$1.04M Sell
3,942
-35
-0.9% -$9.38K 0.65% 48
2022
Q3
$896K Sell
3,977
-110
-3% -$26.7K 0.62% 54
2022
Q2
$994K Hold
4,087
0.64% 52
2022
Q1
$988K Hold
4,087
0.53% 55
2021
Q4
$919K Hold
4,087
0.49% 64
2021
Q3
$869K Sell
4,087
-4
-0.1% -$921 0.5% 65
2021
Q2
$997K Buy
4,091
+37
+0.9% +$9.1K 0.56% 58
2021
Q1
$1.01M Sell
4,054
-32
-0.8% -$7.63K 0.59% 54
2020
Q4
$939K Sell
4,086
-116
-3% -$26.7K 0.63% 51
2020
Q3
$1.07M Sell
4,202
-177
-4% -$43.9K 0.78% 46
2020
Q2
$1.03M Hold
4,379
0.76% 49
2020
Q1
$888K Hold
4,379
0.78% 48
2019
Q4
$1.06M Hold
4,379
0.7% 51
2019
Q3
$847K Hold
4,379
0.6% 55
2019
Q2
$807K Hold
4,379
0.57% 57
2019
Q1
$832K Hold
4,379
0.57% 55
2018
Q4
$852K Sell
4,379
-43
-1% -$8.39K 0.65% 51
2018
Q3
$917K Hold
4,422
0.65% 54
2018
Q2
$816K Hold
4,422
0.61% 55
2018
Q1
$754K Hold
4,422
0.59% 57
2017
Q4
$769K Buy
+4,422
New +$783K 0.57% 55

Other funds holding AMGN

Murphy Middleton Hinkle & Parker's AMGN Position: Q2 2026 in Review

Murphy Middleton Hinkle & Parker held its Amgen (AMGN) position steady in Q2 2026 at 3,661 shares worth $1.33M. The position accounts for 0.54% of the portfolio, ranked #56.

Murphy Middleton Hinkle & Parker first reported a position in AMGN in Q4 2017 and has held it in 34 quarters since. 676 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Murphy Middleton Hinkle & Parker held 3,661 shares of Amgen worth $1.33M as of Q2 2026.
  • Murphy Middleton Hinkle & Parker left its Amgen share count unchanged in Q2 2026.
  • Amgen made up 0.54% of Murphy Middleton Hinkle & Parker's portfolio in Q2 2026, its #56 holding.
  • Murphy Middleton Hinkle & Parker first reported a position in Amgen in Q4 2017 and has held it in 34 quarters since.
  • 676 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Murphy Middleton Hinkle & Parker's 13F filing for Q2 2026, filed 14 Jul 2026.